Cosmo Bio (3386.T) traded down -0.08 % during a 24 hours period ending at 01:28 AM Central Europe on Tuesday 27th. One Cosmo Bio stock can currently be bought for about JPY 1,229 on popular exchanges. Current supply of Cosmo Bio stocks is 5.7 mn. Cosmo Bio has a current market capitalization of JPY 7 bn and approximately JPY 4.8 mn worth of Cosmo Bio was traded on exchanges in the last 24 hours. Since last month end, Cosmo Bio has traded -1.99 % down. Simple moving average of last 200 days is at JPY 1,272.04. The highest price of past 52 weeks was recorded at JPY 1,486 on 11/18/2025. 52 weeks low was at JPY 1,083 on 11/11/2025.
Here is how related stocks have performed in the past 24 hours:
Original Engineering Consult (4642.T) traded down -0.93 % and now trades at JPY 1,398. Original Engineering Consult has a market capitalisation of JPY 8.3 bn. Original Engineering Consult has a current price to earnings ratio of 13.54.
Japan Insulation (5368.T) traded down -0.92 % and now trades at JPY 973. Current market capitalisation for Japan Insulation is JPY 8.4 bn. Japan Insulation has a current price to earnings ratio of 8.07.
Paycloud (4015.T) traded down -1.48 % and now trades at JPY 523. Paycloud has a market capitalisation of JPY 8.4 bn. Current price/earnings ratio for Paycloud is 20.43.
Mental Health C (9218.T) traded down -0.25 % and now trades at JPY 778. Current market capitalisation for Mental Health C is JPY 8.3 bn. Current price/earnings ratio for Mental Health C is 35.39.
Koken (7963.T) traded down -0.23 % and now trades at JPY 1,718. Current market capitalisation for Koken is JPY 8.3 bn. Current price/earnings ratio for Koken is 9.99.
About Cosmo Bio
Cosmo Bio Co Ltd. is a health care company based in Japan that specializes in import, export, manufacturing, marketing, and selling reagents, kits, instruments, software, and diagnostics products both domestically and internationally. It offers a wide range of research reagents for antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, bacteria, and other. Additionally, the company provides detection reagents, cell and tissue culture systems, gene analysis systems, and other. They also offer research instruments such as electrophoresis apparatus, cell culture lab wares, gene manipulation systems, data analysis software, and others. Beyond that, Cosmo Bio Co Ltd. provides drug discovery and custom research services and clinical diagnostics products. The company serves laboratories, research instites, life-science education, and testing organizations. They sell their products through a network of approximately 200 outlets in Japan, as well as through agents. The company was founded in 1978 and is based in Tokyo, Japan. Their webseite is www.cosmobio.co.jp , and they are listed on the Tokyo Stock Exchange. The date of their IPO is September 27, 2005.